Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Athanassios E Argiris, MD
Principal Investigator
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Upmc Cancer Center - Teramana Cancer Center - Steubenville
Steubenville, Ohio, United States
- Upmc Cancer Center - Beaver
Beaver, Pennsylvania, United States
- Upmc Cancer Center - Clairton
Clairton, Pennsylvania, United States
- Upmc Cancer Center - Arnold Palmer Pavilion - Greensburg
Greensburg, Pennsylvania, United States
- Upmc Cancer Center - Oakbrook Commons - Greensburg
Greensburg, Pennsylvania, United States
- Upmc Cancer Center - Indiana
Indiana, Pennsylvania, United States
- Upmc Cancer Center - John P. Murtha Pavilion - Johnstown
Johnstown, Pennsylvania, United States
- Upmc Cancer Center - Mckeesport
McKeesport, Pennsylvania, United States
- Upmc Cancer Center -Haymaker Rd.
Monroeville, Pennsylvania, United States
- Upmc Cancer Center -Mosside Blvd.
Monroeville, Pennsylvania, United States
- Upmc Cancer Center - Sewickley Medical Oncology/hematology Group
Moon Township, Pennsylvania, United States
- Upmc Cancer Center -Mt. Pleasant
Mount Pleasant, Pennsylvania, United States
- Upmc Cancer Center -New Castle
New Castle, Pennsylvania, United States
- Upmc Cancer Center - Mercy
Pittsburgh, Pennsylvania, United States
- Upmc Cancer Center - Passavant
Pittsburgh, Pennsylvania, United States
- Upmc Cancer Center -Delafield Rd.
Pittsburgh, Pennsylvania, United States
- Upmc Cancer Center -Drake
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Cancer Institute-Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
- Upmc Cancer Center - Uniontown
Uniontown, Pennsylvania, United States
- Upmc Cancer Center - Washington
Washington, Pennsylvania, United States
- Upmc Cancer Center -Wexford
Wexford, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 30 Jun 2011
- Completion
- 30 Jun 2011
- Last update posted
- 7 Nov 2016
- Registered enrollment
- 10
- Registry id
- NCT00581360
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.